West Pharmaceutical Services, Inc. (WST) Tops Q3 EPS by 2c; Boosts FY12 EPS Outlook
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q3 EPS of $0.52, $0.02 better than the analyst estimate of $0.50. Revenue for the quarter came in at $303.8 million versus the consensus estimate of $306.91 million.
West Pharmaceutical Services, Inc. sees FY2012 EPS of $2.67-2.72. West Pharmaceutical Services, Inc. sees FY2012 revenue of $1.25-1.27 million, versus the consensus of $1.25 million.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
West Pharmaceutical Services, Inc. sees FY2012 EPS of $2.67-2.72. West Pharmaceutical Services, Inc. sees FY2012 revenue of $1.25-1.27 million, versus the consensus of $1.25 million.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.